Pharmacy Times
JULY 16, 2022
With a lack of head-to-head studies comparing combination regimens in frontline metastatic renal cell carcinoma, deciding on how to choose the right regimen can pose a challenge.
Pharmacy Times
JULY 16, 2022
The investigational PCV is designed to target serotypes responsible for 85% of all invasive cases of the disease in individuals aged 65 and older in the United States.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 16, 2022
With the rapid pace of change in biosimilar payer benefit design, efforts to stay regularly updated on policy changes ahead of time become critical for patient care.
Pharmacy Times
JULY 16, 2022
The nature of CLL being a long-term, incurable disease makes its treatment a challenge as it is more focused toward improving patient’s quality of life.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 16, 2022
Even before the pandemic, pharmacists were playing a really important role in public health, being one of the most accessible health care providers.
Pharmacy Times
JULY 16, 2022
Experts discuss the pros and cons of using oral azacytidine to treat patients with acute myeloid leukemia.
Expert insights. Personalized for you.
123 
Let's personalize your content